Key Takeaways
- scRNA-seq has identified blood-cell subtypes that were not distinguished by surface markers.
- Single-cell data suggest that blood-cell differentiation is more continuous than the classical stepwise model.
- Processing time, isolation method, and pre-sequencing quality control strongly influence data quality.
- Large cohort studies use scRNA-seq to relate cell-type-specific expression to disease subtypes and genetic risk.
What scRNA-Seq Reveals About Blood
PBMC preparations consist primarily of T cells, B cells, NK cells, and monocytes, with smaller dendritic-cell populations and other rare populations depending on the sample and enrichment method. Bulk RNA-seq averages expression across these populations, whereas scRNA-seq profiles captured cells individually.
Identifying New Cell Subtypes
Villani and colleagues performed scRNA-seq on about 2,400 human blood cells (Science, 2017). They described six dendritic-cell subtypes and four monocyte subtypes, including a circulating progenitor of conventional dendritic cells. Several of these populations had not been resolved by standard surface-marker panels.
Capturing Activation States
scRNA-seq also captures cell states. A resting monocyte differs transcriptionally from a monocyte responding to interferon. State information is used to:
- Track immune activation during infection or disease flares.
- Distinguish chronic inflammatory signatures from acute responses.
- Relate expression changes to disease severity in research cohorts.
Differentiation as a Continuum
Trajectory analysis orders cells by gradual expression changes. In blood, it suggests that differentiation proceeds through transitional states rather than discrete steps.
The number of clusters resolved in a PBMC dataset depends on sequencing depth, cell number, and annotation choices. Cluster counts reported in one study should be treated as analysis-specific.
Workflow Considerations for Blood scRNA-Seq
Collection and Cell-State Preservation
Blood scRNA-seq is sensitive to pre-analytical handling because transcriptional states can change during delays even when overall cell viability remains relatively stable. A human blood study found extensive single-cell transcriptomic changes emerging within hours of delayed processing, emphasizing the need for consistent collection-to-processing times (iScience).
Practical priorities include:
- Process samples as promptly and consistently as the validated protocol allows.
- Record collection time, processing time, and storage conditions for each sample.
- Follow platform-specific temperature requirements rather than assuming colder handling is always better.
- Use RNase inhibitors only where the specific cell, nuclei, lysis, or library workflow calls for them.
Isolation Method Trade-offs
PBMCs are commonly isolated by density-gradient centrifugation. Red-blood-cell lysis may be added when residual erythrocyte contamination remains, but it is not an obligatory step after density separation. Alternatively, some workflows isolate leukocytes directly from whole blood using red-cell lysis. Fixation and delayed-processing workflows are platform-specific and should follow the validated chemistry because fixation method and sample handling can affect gene and UMI recovery.
Pre-Sequencing Quality Control
Cells should be counted, checked for viability, and inspected for morphology before loading onto a single-cell platform. Compromised samples identified at this stage can be excluded before sequencing costs are incurred.
Laxco's SeBaPro4 Series digital microscopes integrate camera, computer, and display. They support image capture and documentation for visual QC records.
Isolating Rare Populations
Rare hematopoietic progenitors often need enrichment before single-cell capture, commonly by flow sorting or magnetic selection. When cells are examined in bone-marrow sections rather than suspension, laser capture microdissection (LCM) can isolate selected regions for molecular analysis.
Laxco's Accuva Cellect Laser Capture Microdissection System provides:
- An infrared (IR) laser designed for film capture of single cells or small numbers of cells.
- An ultraviolet (UV) laser designed for cutting dense structures, such as bone.
- A five-step software workflow with visual quality control and documentation.
Accuva Cellect is not a validated blood scRNA-seq protocol. LCM-isolated material is typically analyzed with low-input RNA methods.
Globin Contamination in Blood Workflows
Globin depletion is an important consideration in bulk whole-blood RNA-seq, where hemoglobin transcripts can consume a large fraction of sequencing reads. It is not a routine preprocessing step for standard PBMC-based scRNA-seq workflows, where mononuclear cells are first separated from most erythrocytes.
Residual red-cell contamination can still affect single-cell preparations, so sample cleanup should follow the requirements of the chosen platform. If a specialized whole-blood or fixed-cell single-cell workflow is used, follow that chemistry's validated guidance rather than applying depletion parameters from bulk RNA-seq studies.
Insights into Hematopoiesis
The classical hematopoietic tree was built largely from flow cytometry and surface markers. Single-cell data have refined it.
Continuous Trajectories
A 2021 review by Acosta, Ssozi, and van Galen summarized the single-cell evidence (Arteriosclerosis, Thrombosis, and Vascular Biology, 2021). It described more heterogeneous cell types and more gradual differentiation than the classical model assumed. Separate trajectories can converge on similar mature cell types. Megakaryocytes may arise more directly from stem cells than the classical model suggested.
Pseudotime Analysis
Pseudotime analysis orders cells along an inferred developmental path from multipotent progenitors to mature lineages. It is used to study:
- Megakaryocyte and erythroid commitment.
- Myeloid differentiation branches.
- Lymphoid lineage specification.
Macaulay and colleagues (Cell Reports, 2016) used scRNA-seq to reconstruct continuous thrombocyte differentiation in zebrafish hematopoietic cells. Dahlin and colleagues (Blood, 2018) profiled 44,802 mouse bone-marrow hematopoietic stem and progenitor cells and identified entry points into eight blood lineages.
Heterogeneity in Sorted Populations
Progenitor populations defined by surface markers often contain substantial transcriptional heterogeneity. Cells sorted into the same gate can occupy different points along a differentiation trajectory.
Disease Research Applications
Systemic Lupus Erythematosus
Perez and colleagues profiled more than 1.2 million PBMCs from 162 patients with systemic lupus erythematosus (SLE) and 99 healthy controls (Science, 2022). Reported findings included:
- Two molecular subphenotypes, with the "High" group showing about fivefold higher odds of anti-Smith antibodies.
- Fewer naive CD4+ T cells in patients with SLE, particularly among Asian-ancestry participants.
- Classical monocytes showed the strongest expression of type 1 interferon-stimulated genes. Interferon-related expression modules were inversely associated with circulating naïve CD4+ T-cell abundance; for the Pan-up module, the reported correlations were R = -0.52 in the Asian-ancestry cohort and R = -0.57 in the European-ancestry cohort (Perez et al., Science, 2022).
These results show how patients with similar clinical features can differ at the molecular level. Research cohorts can be stratified by molecular profile as well as clinical presentation.
Blood Cancers
In hematologic malignancies, scRNA-seq can distinguish malignant cells from residual normal cells in the same sample. Van Galen and colleagues (Cell, 2019) profiled nearly 31,000 cells from 16 patients with acute myeloid leukemia (AML), together with healthy-donor cells. They reported:
- Six malignant cell types distributed along the stem-cell-to-myeloid differentiation axis.
- Monocyte-like AML cells that suppressed T-cell activation in vitro.
Cell-Type-Specific Genetic Risk
The OneK1K study (Yazar and colleagues, Science, 2022) analyzed about 1.27 million PBMCs from 982 donors. It mapped expression quantitative trait loci (eQTLs) whose effects are specific to particular cell types, and linked them to autoimmune disease loci. Bulk-tissue eQTL mapping can miss effects confined to one cell type.
Practical Considerations
Cost
Cost depends on platform, number of cells, and sequencing depth. Library preparation and sequencing reagents are the main components. Request a current quote from a core facility or provider before budgeting.
Cell Numbers
Target cell recovery depends on the platform and study question. Because not all loaded cells are recovered, input numbers are set above the target. Rare populations usually require enrichment to be well represented.
Public Data
The Human Cell Atlas Data Portal hosts open single-cell datasets. The Perez lupus dataset is available in GEO under accession GSE174188. Disease-specific consortia also publish blood reference datasets.
Frequently Asked Questions
Why is single-cell resolution useful for studying hematopoiesis?
It captures transitional progenitor states and heterogeneity within populations that surface markers group together. This supports models of continuous differentiation rather than strictly stepwise development.
What are the main technical challenges in blood scRNA-seq?
Major challenges include pre-analytical changes in gene expression during processing delays, loss of viability or cell recovery, shifts in cell-type composition, and residual red-blood-cell contamination. Process samples promptly and consistently, follow the validated temperature conditions for the chosen workflow, and perform platform-appropriate cell-count and viability QC before loading.
Which Laxco tools support pre-sequencing QC?
Laxco's SeBaPro4 Series digital microscopes integrate camera, computer, and display for image capture and documentation. They can support visual checks of cell suspensions before loading.
Can LCM be used for blood-related studies?
LCM applies to tissue sections, such as bone-marrow biopsies, rather than cell suspensions. Accuva Cellect's UV laser is designed for cutting dense structures such as bone, and its IR laser for capturing small numbers of cells.
